NeuPath Health Inc.
NPTH.V
TSX
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -6.73% | 6.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.73% | 6.38% | |||
| Cost of Revenue | -4.71% | 4.36% | |||
| Gross Profit | -14.79% | 15.32% | |||
| SG&A Expenses | 0.32% | 1.67% | |||
| Depreciation & Amortization | 4.33% | -6.22% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.74% | 3.62% | |||
| Operating Income | -80.16% | 208.17% | |||
| Income Before Tax | -163.52% | 246.92% | |||
| Income Tax Expenses | -20.95% | 13.95% | |||
| Earnings from Continuing Operations | -189.49% | 203.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -18.67% | -91.27% | |||
| Net Income | -235.92% | 177.14% | |||
| EBIT | -80.16% | 208.17% | |||
| EBITDA | -43.97% | 55.69% | |||
| EPS Basic | -236.84% | 176.00% | |||
| Normalized Basic EPS | -156.25% | 740.00% | |||
| EPS Diluted | -292.11% | 151.35% | |||
| Normalized Diluted EPS | -156.25% | 740.00% | |||
| Average Basic Shares Outstanding | 0.15% | 0.03% | |||
| Average Diluted Shares Outstanding | -0.12% | 0.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
